INSM5182680 analysis
Key facts
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.